FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011330952> ?p ?o ?g. }

• W2011330952 endingPage "78" @default.
• W2011330952 startingPage "68" @default.
• W2011330952 abstract "Advanced glycation end products (AGEs) accumulate with age and at an accelerated rate in diabetes. AGEs bind cell-surface receptors including the receptor for advanced glycation end products (RAGE). The dependence of RAGE binding on specific biochemical characteristics of AGEs is currently unknown. Using standardized procedures and a variety of AGE measures, the present study aimed to characterize the AGEs that bind to RAGE and their formation kinetics in vitro. To produce AGEs with varying RAGE binding affinity, bovine serum albumin (BSA) AGEs were prepared with 0.5 M glucose, fructose, or ribose at times of incubation from 0 to 12 weeks or for up to 3 days with glycolaldehyde or glyoxylic acid. The AGE-BSAs were characterized for RAGE binding affinity, fluorescence, absorbance, carbonyl content, reactive free amine content, molecular weight, pentosidine content, and N-ε-carboxymethyl lysine content. Ribose-AGEs bound RAGE with high affinity within 1 week of incubation in contrast to glucose- and fructose-AGE, which required 12 and 6 weeks, respectively, to generate equivalent RAGE ligands (IC50=0.66, 0.93, and 1.7 μM, respectively). Over time, all of the measured AGE characteristics increased. However, only free amine content robustly correlated with RAGE binding affinity. In addition, detailed protocols for the generation of AGEs that reproducibly bind RAGE with high affinity were developed, which will allow for further study of the RAGE–AGE interaction." @default.
• W2011330952 created "2016-06-24" @default.
• W2011330952 creator A5007541805 @default.
• W2011330952 creator A5022435053 @default.
• W2011330952 creator A5033941944 @default.
• W2011330952 creator A5060980699 @default.
• W2011330952 creator A5061359578 @default.
• W2011330952 creator A5085468214 @default.
• W2011330952 creator A5086269203 @default.
• W2011330952 date "2004-01-01" @default.
• W2011330952 modified "2023-10-12" @default.
• W2011330952 title "Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics" @default.
• W2011330952 cites W1503258737 @default.
• W2011330952 cites W1504092669 @default.
• W2011330952 cites W1518714662 @default.
• W2011330952 cites W1594856996 @default.
• W2011330952 cites W1973852753 @default.
• W2011330952 cites W1976068063 @default.
• W2011330952 cites W1981047164 @default.
• W2011330952 cites W1983577234 @default.
• W2011330952 cites W1995180560 @default.
• W2011330952 cites W2000767359 @default.
• W2011330952 cites W2005640704 @default.
• W2011330952 cites W2018598987 @default.
• W2011330952 cites W2019522259 @default.
• W2011330952 cites W2025016154 @default.
• W2011330952 cites W2035899511 @default.
• W2011330952 cites W2041875988 @default.
• W2011330952 cites W2048441160 @default.
• W2011330952 cites W2052681712 @default.
• W2011330952 cites W2056196448 @default.
• W2011330952 cites W2057616008 @default.
• W2011330952 cites W2063284869 @default.
• W2011330952 cites W2064532629 @default.
• W2011330952 cites W2065012620 @default.
• W2011330952 cites W2071675524 @default.
• W2011330952 cites W2073173912 @default.
• W2011330952 cites W2075422811 @default.
• W2011330952 cites W2077088113 @default.
• W2011330952 cites W2084536221 @default.
• W2011330952 cites W2089315626 @default.
• W2011330952 cites W2089878313 @default.
• W2011330952 cites W2096528326 @default.
• W2011330952 cites W2106697731 @default.
• W2011330952 cites W2117937531 @default.
• W2011330952 cites W2119150369 @default.
• W2011330952 cites W2130670511 @default.
• W2011330952 cites W2132517655 @default.
• W2011330952 cites W2149342137 @default.
• W2011330952 cites W2162392951 @default.
• W2011330952 cites W2165519954 @default.
• W2011330952 cites W4293775696 @default.
• W2011330952 doi "https://doi.org/10.1016/j.ab.2003.09.013" @default.
• W2011330952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14654047" @default.
• W2011330952 hasPublicationYear "2004" @default.
• W2011330952 type Work @default.
• W2011330952 sameAs 2011330952 @default.
• W2011330952 citedByCount "165" @default.
• W2011330952 countsByYear W20113309522012 @default.
• W2011330952 countsByYear W20113309522013 @default.
• W2011330952 countsByYear W20113309522014 @default.
• W2011330952 countsByYear W20113309522015 @default.
• W2011330952 countsByYear W20113309522016 @default.
• W2011330952 countsByYear W20113309522017 @default.
• W2011330952 countsByYear W20113309522018 @default.
• W2011330952 countsByYear W20113309522019 @default.
• W2011330952 countsByYear W20113309522020 @default.
• W2011330952 countsByYear W20113309522021 @default.
• W2011330952 countsByYear W20113309522022 @default.
• W2011330952 countsByYear W20113309522023 @default.
• W2011330952 crossrefType "journal-article" @default.
• W2011330952 hasAuthorship W2011330952A5007541805 @default.
• W2011330952 hasAuthorship W2011330952A5022435053 @default.
• W2011330952 hasAuthorship W2011330952A5033941944 @default.
• W2011330952 hasAuthorship W2011330952A5060980699 @default.
• W2011330952 hasAuthorship W2011330952A5061359578 @default.
• W2011330952 hasAuthorship W2011330952A5085468214 @default.
• W2011330952 hasAuthorship W2011330952A5086269203 @default.
• W2011330952 hasConcept C147990577 @default.
• W2011330952 hasConcept C169760540 @default.
• W2011330952 hasConcept C170493617 @default.
• W2011330952 hasConcept C185592680 @default.
• W2011330952 hasConcept C25642318 @default.
• W2011330952 hasConcept C2776016237 @default.
• W2011330952 hasConcept C2776997535 @default.
• W2011330952 hasConcept C2778857457 @default.
• W2011330952 hasConcept C2780758796 @default.
• W2011330952 hasConcept C515207424 @default.
• W2011330952 hasConcept C55493867 @default.
• W2011330952 hasConcept C86803240 @default.
• W2011330952 hasConceptScore W2011330952C147990577 @default.
• W2011330952 hasConceptScore W2011330952C169760540 @default.
• W2011330952 hasConceptScore W2011330952C170493617 @default.
• W2011330952 hasConceptScore W2011330952C185592680 @default.
• W2011330952 hasConceptScore W2011330952C25642318 @default.
• W2011330952 hasConceptScore W2011330952C2776016237 @default.
• W2011330952 hasConceptScore W2011330952C2776997535 @default.
• W2011330952 hasConceptScore W2011330952C2778857457 @default.

• next